The Biotechnology Institute in Arlington, Va., appointed Mary Cassoni to its board.
MGI Pharma Inc., of Minneapolis, appointed Martin Duvall senior vice president, commercial operations.
Myogen Inc., of Denver, appointed Andrew Dickinson vice president, general counsel and secretary.
NeuroNova AB, of Stockholm, Sweden, appointed Ulf Ljungberg president and CEO.
Northfield Laboratories Inc., of Evanston, Ill., appointed Laurel Omert chief medical officer.
OpGen Inc., of Madison, Wis., appointed Joseph Shaw CEO and to its board.
Quantum Dot Corp., of Hayward, Calif., appointed Janet Lankard vice president, sales.
Synovis Life Technologies Inc., of St. Paul, Minn., appointed Mark Palma and Sven Wehrwein to its board.
The Medicines Co., of Parsippany, N.J., appointed John Kelley president and chief operating officer.
Voyager Pharmaceutical Corp., of Raleigh, N.C., appointed Connie Powers senior clinical scientist, Jamie Gault senior regulatory affairs manager and Maria Kononova research scientist.
XTL Biopharmaceuticals Ltd., of Rehovot, Israel, appointed Michael Weiss nonexecutive director.